BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8620345)

  • 1. Triiodothyronine exerts a major pleiotropic effect on reverse cholesterol transport phenotypes.
    Comuzzie AG; Blangero J; Mahaney MC; Sharp RM; VandeBerg JL; Stern MP; MacCluer JW
    Arterioscler Thromb Vasc Biol; 1996 Feb; 16(2):289-93. PubMed ID: 8620345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of endurance exercise training on plasma lipoprotein AI and lipoprotein AI:AII concentrations in sedentary adults.
    Wilund KR; Colvin PL; Phares D; Goldberg AP; Hagberg JM
    Metabolism; 2002 Aug; 51(8):1053-60. PubMed ID: 12145781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo metabolism of apo A-I and apo A-II in subjects with apo A-I(Lys107-->0) associated with reduced HDL cholesterol and Lp(AI w AII) deficiency.
    Tilly-Kiesi M; Packard CJ; Kahri J; Ehnholm C; Shepherd J; Taskinen MR
    Atherosclerosis; 1997 Feb; 128(2):213-22. PubMed ID: 9050778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein AI- and AI:AII-containing lipoproteins in white men and women of the HERITAGE Family study: Associations with metabolic risk profile variables.
    Couillard C; Bergeron J; Després JP; Gagnon J; Rankinen T; Leon AS; Rao DC; Skinner JS; Wilmore JH; Bouchard C
    Metabolism; 2003 Dec; 52(12):1530-6. PubMed ID: 14669150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between apolipoprotein AI-containing lipoprotein fractions and environmental factors: the prospective epidemiological study of myocardial infarction (PRIME study).
    Luc G; Bard JM; Evans A; Arveiler D; Ruidavets JB; Amouyel P; Ducimetiere P
    Atherosclerosis; 2000 Oct; 152(2):399-405. PubMed ID: 10998468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probucol promotes reverse cholesterol transport in heterozygous familial hypercholesterolemia. Effects on apolipoprotein AI-containing lipoprotein particles.
    Adlouni A; El Messal M; Saïle R; Parra H; Fruchart J; Ghalim N
    Atherosclerosis; 2000 Oct; 152(2):433-40. PubMed ID: 10998472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDL subparticles and coronary artery disease in NIDDM.
    O'Brien T; Nguyen TT; Hallaway BJ; Hodge D; Bailey K; Kottke BA
    Atherosclerosis; 1996 Apr; 121(2):285-91. PubMed ID: 9125302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux.
    Cheung MC; Mendez AJ; Wolf AC; Knopp RH
    J Clin Invest; 1993 Feb; 91(2):522-9. PubMed ID: 8432861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderate red wine consumption in healthy volunteers reduced plasma clearance of apolipoprotein AII.
    Gottrand F; Beghin L; Duhal N; Lacroix B; Bonte JP; Fruchart JC; Luc G
    Eur J Clin Invest; 1999 May; 29(5):387-94. PubMed ID: 10354195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunofractionation of high density lipoprotein subclasses 2 and 3. Similarities and differences of fractions isolated from male and female populations.
    James RW; Pometta D
    Atherosclerosis; 1990 Jul; 83(1):35-45. PubMed ID: 2117929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the treatment of hypothyroidism and hyperthyroidism on plasma lipids and apolipoproteins AI, AII and E.
    O'Brien T; Katz K; Hodge D; Nguyen TT; Kottke BA; Hay ID
    Clin Endocrinol (Oxf); 1997 Jan; 46(1):17-20. PubMed ID: 9059553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary fat saturation affects apolipoprotein AII levels and HDL composition in postmenopausal women.
    Sánchez-Muniz FJ; Merinero MC; Rodríguez-Gil S; Ordovas JM; Ródenas S; Cuesta C
    J Nutr; 2002 Jan; 132(1):50-4. PubMed ID: 11773507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shared and unique genetic effects among seven HDL phenotypes.
    Comuzzie AG; Rainwater DL; Blangero J; Mahaney MC; VandeBerg JL; MacCluer JW
    Arterioscler Thromb Vasc Biol; 1997 May; 17(5):859-64. PubMed ID: 9157948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between high-density lipoprotein subpopulations in apo B-free and abetalipoproteinemic plasma.
    Cheung MC; Wolf AC; Illingworth DR
    Biochim Biophys Acta; 1992 Oct; 1128(2-3):244-9. PubMed ID: 1420297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.
    Kempen HJ; van Gent CM; Buytenhek R; Buis B
    J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein AI and AII metabolism in patients with primary high-density lipoprotein deficiency associated with familial hypertriglyceridemia.
    Saku K; Gartside PS; Hynd BA; Mendoza SG; Kashyap ML
    Metabolism; 1985 Aug; 34(8):754-64. PubMed ID: 3927110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
    Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH
    Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precipitation procedures used to isolate high density lipoprotein with particular reference to effects on apo A-I-only particles and lipoprotein(a).
    Vallance DT; Byrne DJ; Winder AF
    Clin Chim Acta; 1994 Sep; 229(1-2):77-85. PubMed ID: 7988057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential role of apolipoprotein AI-containing particles in cholesterol efflux from adipose cells.
    Barkia A; Puchois P; Ghalim N; Torpier G; Barbaras R; Ailhaud G; Fruchart JC
    Atherosclerosis; 1991 Apr; 87(2-3):135-46. PubMed ID: 1906713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice.
    Holvoet P; Danloy S; Deridder E; Lox M; Bernar H; Dhoest A; Collen D
    J Clin Invest; 1998 Jul; 102(2):379-85. PubMed ID: 9664079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.